Adamas Pharmaceuticals $59 million stock offering
We advised the joint book-running managers on the SEC-registered equity offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AVITA Medical $69.1 million follow-on offering
We advised the underwriters on the equity offering
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Ayala Pharmaceuticals $25 million private placement
We advised the placement agent on the private placement of stock and warrants
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
New Horizon Health HK$2.04 billion IPO
We advised New Horizon Health on its IPO and HKEX listing
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
Corvus Pharmaceuticals $34 million stock offering
We advised the underwriters on the equity offering
Biogen exchange offer
We advised the dealer managers on a debt exchange offer